On Models for Integrative Medical Practice
At the Integrative Cancer Therapies (ICT) editorial office, we have been publishing a journal on integrative cancer treatment for 6 years now. One would think that by this time, everyone in health care would be pretty clear about just what integrative treatment means. While that's true in general, in practice there is substantial variability in the implementation and outcomes of integrative medicine. I have been contemplating the question of the varieties of integrative treatment for the past several weeks, ever since I began preparing for a presentation in a session on models of integrative oncology at a recent professional meeting.
So what is integrative treatment, anyhow? The Academic Consortium for Integrative Medicine, a group of more than 35 academic medical centers that do teaching or research in integrative medicine or that maintain integrative clinics, defines it this way: "Integrative Medicine is the practice of medicine that reaffirms the importance of the relationship between practitioner and patient, focuses on the whole person, is informed by evidence, and makes use of all appropriate therapeutic approaches, healthcare professionals and disciplines to achieve optimal health and healing." 1 Some parts of this definition, it should be said, apply to all truly good medicine, whether it is complementary, alternative, integrative, or conventional. Optimally effective practitioners all affirm the importance of the practitioner-patient relationship, focus on the whole person, and are informed by evidence. The difference between integrative health care and strictly conventional care comes in the last part of the definition-making use of all appropriate approaches, health care professions, and disciplines. This is where practitioners of a range of disciplines, from medical oncology to nutrition to massage or reflexology, can work together on caring for patients.
This definition is certainly accurate, but it is not very specific. Heather Boon and colleagues went quite a long way toward further specifying ways that one could practice integrative medicine in a 2004 paper in BMC Health Services Research. 2 In this article, they discuss a conceptual framework that specifies 7 different models of implementing integrative medical practice. They note that "integrative health care" describes teams of health care providers working together using both complementary and alternative medicine and conventional approaches. They also note that integrative health care means different things to different people, and it is this issue that they set out to clarify with their conceptual framework.
The 7 practice models that they describe are as follows:
Parallel practice: Independent health care practitioners working in a common setting who each work within their own, formally defined scopes of practice. In this case, it is likely the common setting for the different practitioners (presumably both complementary or alternative medicine [CAM] and conventional) that makes this an integrative model. Consultative practice: Experts in different fields (CAM and conventional) give each other advice through personal communication, formal letters, or referral notes. An article in the June 2007 issue of ICT gave a thorough description of a consultative-model practice maintained at the University of Arizona. 3 Collaborative practice: On an ad hoc basis, CAM and conventional practitioners who usually practice independently share information concerning a particular patient who is being treated by both of them. This seems somewhat related to what one might call "patientinitiated integrative medicine," in which patients decide that they are going to integrate their own health care and solicit or stimulate such information sharing among the different practitioners they see. Coordinated practice: A formalized administrative structure that requires communication and sharing patient records among a team of CAM and conventional practitioners who provide treatment for a particular disease; a case manager coordinates information transfer between practitioners and to the patient. Multidisciplinary practice: Teams managed by leaders (generally not conventional physicians) plan patient care; some individual(s) usually directs services of a range of practitioners who may or may not meet faceto-face. Recommendations from these independent practitioners may be integrated by a team leader. Interdisciplinary practice: This emerges from a multidisciplinary practice when the different practitioners on the team begin to meet formally and face-to-face, arriving at decisions on patient care through a consensus model. Integrative practice: Interdisciplinary and nonhierarchical blending of CAM and conventional practitioners that provides a seamless continuum of decision making and patient care and support. It is based on core values that include whole-person care, assisting innate healing properties of the individual, and promoting health and wellness. The multidisciplinary team is guided by consensus building and mutual respect, as well as a shared vision of health that permits each practitioner to contribute to a synergistically structured plan of care.
It is clear from this listing that integrative care could indeed mean very different things to different people. Integrative care could take place all over town, or all over the country, in the collaborative model. It would take place in a single clinic in the integrative model. Perhaps different patients would, given the choice, elect different models of integrative care. Some may, indeed, prefer to guide their own care in a collaborative model. Others may want the full range of coordinated services available at a single clinic that is implied by the integrative model.
It is also clear in the article that the authors actually regard the integrative model as the most advanced and developed of the different models in terms of actually delivering a coherent program of CAM and conventional therapies to patients. Boon et al 2 point out that as one moves from the parallel to the integrative models, some core values increase. The emphasis on the whole person, the diversity of health care philosophies incorporated into treatment, and the number of determinants of health care, for instance, is much higher in the integrative model than in the parallel model. Similarly, the complexity of structure and outcome, synergy, consensus, and communication increase in the integrative model compared to the other models.
As an active practitioner in a cancer treatment facility using the integrative model, I do believe that the integrative model of Boon et al 2 is, indeed, the most advanced and developed of their models. It also seems to me to be the closest to what the basic concept of integrative medicine implies. Mutual respect among practitioners, leveraging the effectiveness of overall care through synergy, and seamless decision making in which complementary and conventional practitioners offer a unified program to the patient are all important goals of integrative practice and are implemented in our facility. In our practice, and in my conception of how integrative practice in general should function, cancer patients receive conventional treatment (chemotherapy in our case) while they are going through nutrition counseling, having individual and group counseling in exercise or yoga, getting massages, and participating in group or individual sessions on psychosocial issues. My preference is to have these activities all occur under the same roof, and we do achieve this with patients receiving chemotherapy at our center. Specifically, they participate in all these CAM activities at the clinic where they receive chemotherapy and, in fact, during their chemotherapy sessions. For patients receiving chemotherapy at other clinics, as well as those who have finished active conventional treatment, consultations on lifestyle issues and treatment by CAM practitioners are, of course, also available.
The total intervention is guided by detailed lab and clinical assessments, as well as a scientific rationale based on analysis of the literature in all our CAM areas as it applies to cancer, in addition to the experience and knowledge of the practitioners. Our oncology and nursing teams meet weekly in Tumor Board and planning meetings to review patient care. Delivery of the complementary interventions by different practitioners (dietitians, physical therapists, massage therapists, etc) is codified in patient manuals, as well as by meetings of the complementary care staff to discuss patient care and patterns of treatment. Along with regular meetings, communication among the conventional and integrative staff takes place through common access to patients' electronic medical records, which contain detailed information on both the conventional and complementary/alternative interventions and clinical visits of each patient.
CAM and conventional staff are in the same clinic and, in some cases, in the same individual office spaces. Physicians in the practice are familiar with all the CAM interventions, actively support patients in working with the CAM practitioners, and share in the continuing process of keeping staff updated on the relevant CAM and conventional literature. The operation is facilitated by substantial support from a research staff and an administrative staff who are accustomed to the elaborate scheduling routines needed to deliver comprehensive integrative care to patients.
I do note some aspects of how this practice operates that are counter to the description of integrative practice in the article of Boon et al. 2 For instance, these authors predict that reliance on the biomedical scientific model would be less in integrative practice than in parallel practice. We do not find that this is the case. We have a strong reliance on science and biomedicine, both in our use of conventional care and in our search for scientific validation for the CAM elements of the program-and such validation is becoming more common.
Boon et al 2 also predict that hierarchy and clearly defined roles will decrease as practices move in a more integrative direction. Hierarchy and defined roles are, for better or for worse, inevitable parts of current medical practice. Although medical treatments must be administered under the direction of MDs, patients also tend to be more adherent to integrative interventions when they are advised and supported by an MD. Treatment administration, training, and support for patients participating in integrative treatments should come from the CAM practitioners themselves. In my experience, it is not the absence of hierarchy and defined roles that enable this integrative practice to function-it is the integration of these roles into a hierarchy that is necessary for clinical and practical reasons but that is structured to support a comprehensive approach to care. As Boon et al 2 point out, "integrative" medicine as it is now generally understood can refer to any of their 7 models (or perhaps even other models). "Integrative" medicine clinics can be in different buildings or even in different towns than the conventional facilities they are linked to. Communication between CAM and conventional practitioners can happen in many different ways or not at all. We need substantially more research into questions of how such different practice models function and how they may (or may not) meet the needs of patients in different situations. With the publication of the article of Koithan et al in our June issue, we have taken a step in the direction of communicating research in this area. We plan to publish more articles in later issues that address the question of how different types of integrative clinics function. For now, we would simply advise researchers and administrators to bear in mind the differences in these practice models and remain open to the possibility of evolving existing parallel or consultative practices in the direction of genuinely integrative practice as defined by Boon et al. 2 The articles in this issue of ICT deal with subjects ranging from the molecular to the psychological. A large review by Valerie Eschiti covers the subject of which types of CAM are used by patients with different cancer diagnoses. Eschiti examines the many studies that have asked cancer patients about what kinds of CAM therapies they use. Her particular interest is to see whether there are distinct patterns of use among different types of cancer or whether all the different types of cancer patients use more or less the same types of CAM. Her goal in the study is to help clinicians determine how closely they need to question patients about different types of CAM therapies-specifically, whether women with gynecological cancers have a pattern of use that differs from other cancers.
Marja Verhoef and colleagues present a particularly interesting qualitative study concerning the issue of where cancer patients obtain information to guide their uses of CAM therapies, as well as the extent to which evidence-based studies play a role in their evaluation of therapies. The reader may not be surprised to learn that patients are paying little attention to evidence-based studies. In contrast to quantitative studies, the qualitative analysis that these authors carried out allows us to penetrate more deeply into what is going on in the actual decision-making process of cancer patients using CAM.
A population-based study by Beena Patel and colleagues in Ahmedabad, India, examines the relationship of oxidation to the level of cancer risk and cancer survival in normal subjects who used or did not use tobacco and in patients with oral cancer. An interesting feature of the population they examined is the high prevalence of tobacco chewers in the cancer patient group-77 of the 140 patients surveyed chewed tobacco, 34 both chewed and smoked tobacco, and 29 only smoked tobacco. The authors mention betel nut chewing in the introduction to the article. Betel nut chewing is a common habit in the Pacific Islands and Southeast Asia. The betel nut, the fruit of the palm Areca catechu, contains psychoactive alkaloids with a mild stimulating effect. It is commonly combined with lime and with other natural substances such as clove or cardamom. This mixture is wrapped in the leaf of the betel pepper, Piper betle, a relative of black pepper, and the entire mixture is chewed. Tobacco is often added to the betel nut mixture. Betel nut itself is a carcinogen, and the betel chewing habit can result in very high rates of oral cancer in countries where it is common. Using tobacco along with it obviously only aggravates the carcinogenicity. Patel and colleagues report on the levels of variables related to oxidative stress, which can result from both betel and tobacco use. Their observation suggests that oxidation-related variables predict survival in the cancer patient population, making the supply of antioxidants in the diet of these patients a critical issue.
Robert Newman and colleagues at the Pharmaceutical Development Center at MD Anderson Cancer Center report on the use of a cardiac glycoside isolated from the oleander plant in cancer. The use of cardiac glycosides in cancer treatment is receiving research attention based on the observation that digitoxin at low concentrations caused apoptosis in cancer cell lines. In this case, the cardiac glycoside is oleandrin, one of the oleander toxins, and the mechanism of cell death is the less wellknown process of autophagy rather than apoptosis.
Geeta Chaudhary, along with colleagues from the University of Rajasthan, has contributed an article on the chemopreventive effects of Aloe vera. This in vivo study uses both observation of papilloma growth in a mouse model and assays of glutathione, lipid peroxidation, and other relevant variables to determine the potential of this well-known plant species to prevent cancer. Interestingly, extracts of both aloe gel and entire aloe leaves were used. Aloe gel, the clear inner portion of the aloe leaf, is known as a burn treatment and has interesting polysaccharides such as acemannan, used for the treatment of minor wounds and burns. The outer layer of the leaf, traditionally a source of a laxative latex, contains anthraquinone glycosides such as aloin and emodin, for which anticancer activities have been reported in the past. This makes the materials studied by Chaudhary et al an interesting combination product.
A combination of different herbs was also studied by a group from China led by JianHua Wang. In an unusual approach for an in vitro study, they examined a Chinese herbal combination used for cancer treatment in their hospital, "Chinese herbs of Shenghe Powder"; performed a standard herbal extraction technique; and applied this extract of multiple plant species together to chemotherapy drug-resistant cancer cells. Resistance to chemotherapy drugs usually involves several different mechanisms of activity. The goal of Wang and colleagues was to see whether a multicomponent product could target multiple pathways of chemotherapy resistance. This is an exciting approach for a laboratory study and is encouraging in that it is a closer approximation of the realities of integrative traditional Chinese medicine (TCM) practice than simply taking each extract alone and testing it against single drug resistance pathways.
The potential value of multitargeting in cancer care is a common theme of this journal. Two scientists from the Amala Cancer Research Center in India provide an example of how 2 isothiocyanates commonly found in cruciferous vegetables affect multiple targets in an angiogenesis model. P. Thejass and frequent ICT contributor Girija Kuttan present data on how these dietary components affect vascular endothelial growth factor (VEGF), interleukin-2 (IL-2), IL-1β, IL-6, granulocyte-macrophage colonystimulating factor (GM-CSF), and tumor necrosis factor-α (TNF-α) and tissue inhibitor of metalloproteinases (TIMP), all factors related to angiogenesis and inflammation.
Dr Kuttan also has submitted 2 other articles for this issue. One is with C. Gurumala and concerns the effects of Biophytum sensitivum on apoptosis-related endpoints in B-16 melanoma cells. They report effects on iNOS, bcl-2, caspase-3, and p53 mRNA. Interestingly, this member of the Oxalidaceae, or wood sorrel, plant family is one of a small number of plants that can move their leaves. Like the Venus flytrap, the leaves of this species move, folding down when they are disturbed-thus the Latin species name sensitivum. The species is used in Asian traditional medicine for conditions such as diabetes, inflammation, and high cholesterol.
With K. A. Manu and P. V. Leyon, Dr Kuttan has also contributed a study to this issue on the use of Boerhaavia diffusa to prevent gamma irradiationinduced damage in mice. This article discusses the ability of B. diffusa to prevent declines in white blood cell count, liver damage, lipid peroxidation, and DNA damage in mice that receive total body irradiation. Studies of this sort are the initial steps necessary to develop radioprotectors that may be clinically useful when taken during radiation therapy. Obviously, much more needs to be done on an herbal radioprotector of this sort before we could know whether it would be clinically useful or whether it would offer protection to tumors as well as normal cells.
